SG11201702116VA - Viral rna segments as immunomodulatory agents and vaccine components - Google Patents
Viral rna segments as immunomodulatory agents and vaccine componentsInfo
- Publication number
- SG11201702116VA SG11201702116VA SG11201702116VA SG11201702116VA SG11201702116VA SG 11201702116V A SG11201702116V A SG 11201702116VA SG 11201702116V A SG11201702116V A SG 11201702116VA SG 11201702116V A SG11201702116V A SG 11201702116VA SG 11201702116V A SG11201702116V A SG 11201702116VA
- Authority
- SG
- Singapore
- Prior art keywords
- viral rna
- immunomodulatory agents
- vaccine components
- rna segments
- segments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
- C07K14/1816—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus
- C07K14/1833—Hepatitis C; Hepatitis NANB
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/17—Immunomodulatory nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462051727P | 2014-09-17 | 2014-09-17 | |
PCT/US2015/049167 WO2016044023A1 (en) | 2014-09-17 | 2015-09-09 | Viral rna segments as immunomodulatory agents and vaccine components |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201702116VA true SG11201702116VA (en) | 2017-04-27 |
Family
ID=55533694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201702116VA SG11201702116VA (en) | 2014-09-17 | 2015-09-09 | Viral rna segments as immunomodulatory agents and vaccine components |
Country Status (10)
Country | Link |
---|---|
US (1) | US10493141B2 (ko) |
EP (1) | EP3194595A4 (ko) |
JP (1) | JP2017530968A (ko) |
KR (1) | KR20170066433A (ko) |
CN (1) | CN107002079A (ko) |
AU (1) | AU2015318283A1 (ko) |
BR (1) | BR112017005524A2 (ko) |
CA (1) | CA2961568A1 (ko) |
SG (1) | SG11201702116VA (ko) |
WO (1) | WO2016044023A1 (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA42502A (fr) | 2015-07-21 | 2018-05-30 | Modernatx Inc | Vaccins contre une maladie infectieuse |
US11364292B2 (en) | 2015-07-21 | 2022-06-21 | Modernatx, Inc. | CHIKV RNA vaccines |
EP3364950A4 (en) | 2015-10-22 | 2019-10-23 | ModernaTX, Inc. | VACCINES AGAINST TROPICAL DISEASES |
WO2019055807A1 (en) | 2017-09-14 | 2019-03-21 | Modernatx, Inc. | RNA VACCINES AGAINST ZIKA VIRUS |
CN111615397A (zh) | 2017-11-03 | 2020-09-01 | 武田疫苗股份有限公司 | 寨卡疫苗和免疫原性组合物及其使用方法 |
CN111601885A (zh) | 2017-11-30 | 2020-08-28 | 武田疫苗股份有限公司 | 用于将寨卡病毒灭活的方法和相关方法 |
EP3814492A4 (en) | 2018-06-29 | 2022-02-23 | Wuhan Neurophth Biotechnology Limited Company | COMPOSITIONS AND METHODS OF TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY |
WO2020038352A1 (en) * | 2018-08-20 | 2020-02-27 | Wuhan Neurophth Biological Technology Limited Company | Compositions and methods for treating leber's hereditary optic neuropathy |
CA3109432A1 (en) | 2018-08-20 | 2020-02-27 | Wuhan Neurophth Biotechnology Limited Company | Compositions and methods for treating leber's hereditary optic neuropathy |
CN113025633A (zh) | 2019-12-09 | 2021-06-25 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001249928A1 (en) | 2000-04-06 | 2001-10-23 | University Of Iowa Research Foundation | Full-length gb virus c (hepatitis g virus) rna transcripts are infectious in primary cd4 positive t cells and methods of treating hiv |
RU2319505C2 (ru) | 2001-12-18 | 2008-03-20 | Иннодженетикс Н.В. | Очищенные оболочечные белки вируса гепатита с для диагностического и терапевтического применения |
US7291723B2 (en) | 2002-10-24 | 2007-11-06 | University Of Iowa Research Foundation | GB virus C and methods of treating viral infections |
DK1620544T3 (en) * | 2003-04-17 | 2019-01-14 | Alnylam Pharmaceuticals Inc | MODIFIED iRNA AGENTS |
WO2004108159A2 (en) | 2003-06-05 | 2004-12-16 | The University Of Iowa Research Foundation | Gb virus c (hepatitis g virus) for the treatment of hiv |
WO2005047481A2 (en) | 2003-11-12 | 2005-05-26 | Progenics Pharmaceuticals, Inc. | Novel sequences encoding hapatitis c virus glycoproteins |
WO2009120306A1 (en) | 2008-03-25 | 2009-10-01 | Trustees Of Boston University | Multivalent vaccine vector for the treatment and inhibition of viral infection |
CN102206256B (zh) | 2011-03-10 | 2014-06-04 | 中国人民解放军第二军医大学 | 删除了高变区1的hcv包膜e2蛋白及其用途 |
US9611301B2 (en) | 2012-03-20 | 2017-04-04 | The University Of Iowa Research Foundation | GB virus C (hepatitis G virus) E2 glycoprotein as an immunomodulatory agent |
WO2014152271A1 (en) | 2013-03-15 | 2014-09-25 | The University Of Iowa Reseach Foundation | Viral proteins as immunomodulaltory agents and vaccine components |
-
2015
- 2015-09-09 CN CN201580057876.2A patent/CN107002079A/zh active Pending
- 2015-09-09 US US15/510,315 patent/US10493141B2/en active Active
- 2015-09-09 KR KR1020177010116A patent/KR20170066433A/ko unknown
- 2015-09-09 SG SG11201702116VA patent/SG11201702116VA/en unknown
- 2015-09-09 CA CA2961568A patent/CA2961568A1/en not_active Abandoned
- 2015-09-09 EP EP15842717.9A patent/EP3194595A4/en not_active Ceased
- 2015-09-09 BR BR112017005524A patent/BR112017005524A2/pt not_active Application Discontinuation
- 2015-09-09 WO PCT/US2015/049167 patent/WO2016044023A1/en active Application Filing
- 2015-09-09 AU AU2015318283A patent/AU2015318283A1/en not_active Abandoned
- 2015-09-09 JP JP2017514881A patent/JP2017530968A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2017530968A (ja) | 2017-10-19 |
CA2961568A1 (en) | 2016-03-24 |
CN107002079A (zh) | 2017-08-01 |
BR112017005524A2 (pt) | 2018-03-06 |
KR20170066433A (ko) | 2017-06-14 |
EP3194595A1 (en) | 2017-07-26 |
WO2016044023A1 (en) | 2016-03-24 |
US20180000925A1 (en) | 2018-01-04 |
EP3194595A4 (en) | 2018-06-20 |
US10493141B2 (en) | 2019-12-03 |
AU2015318283A1 (en) | 2017-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255847A1 (zh) | 針對乙型肝炎病毒的疫苗 | |
HK1243463A1 (zh) | 檢測rna病毒的組合物和方法 | |
ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
IL250331A0 (en) | Flagellin-based agents and uses including effective vaccination | |
IL286265A (en) | A new tilapia virus and its uses | |
GB201410971D0 (en) | Vaccine | |
SG11201702116VA (en) | Viral rna segments as immunomodulatory agents and vaccine components | |
GB201518684D0 (en) | Vaccine | |
SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
PL3185899T3 (pl) | Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd | |
IL247185B (en) | Tilapia virus vaccines | |
IL287985A (en) | A peptide derived from koc1 and a component containing it | |
GB201522132D0 (en) | Vaccine | |
GB201616904D0 (en) | Vaccine | |
HUE053284T2 (hu) | Vakcina | |
GB201605099D0 (en) | HCV vaccines | |
GB201417214D0 (en) | Vaccine | |
IL249705B (en) | Influenza virus vaccines and their uses | |
IL249704A0 (en) | Influenza virus vaccines and their uses | |
GB201603029D0 (en) | Vaccine | |
GB201408046D0 (en) | Virus preparations | |
GB201507529D0 (en) | Virus preparations | |
GB201406628D0 (en) | Vaccine |